Tesamorelin 10mg - COA Certified - Research Grade Peptide
🧬 Tesamorelin Peptide — 10 mg
High‑Purity GHRH Analog for Endocrine Signaling, Metabolic Pathway & Cellular Regulation Research (Canada)
Tesamorelin is a high‑purity, research‑grade synthetic Growth Hormone–Releasing Hormone (GHRH) analog widely referenced in laboratory research involving pituitary‑axis signaling, GH/IGF‑1‑linked transcriptional pathways, metabolic‑regulation models, and peptide–receptor interaction dynamics.
Supplied by BlueNexLabs, Tesamorelin is provided as a lyophilized peptide (10 mg) with COA‑verified purity, analytical consistency, and audit‑safe Research‑Use‑Only (RUO) labeling, supporting reproducible experimental workflows in Canadian research environments.
🔬 Overview of Tesamorelin in Research Settings
Tesamorelin is a stabilized 44‑amino‑acid GHRH analog designed to support controlled investigation of endocrine‑axis communication and downstream metabolic signaling. In laboratory settings, it is frequently referenced in studies examining:
Pituitary‑axis and GHRH receptor (GHRH‑R) signaling
GH/IGF‑1‑associated transcriptional cascades
Metabolic‑regulation and lipid‑signaling pathways
Cellular growth and protein‑synthesis models
Peptide stability and receptor‑binding kinetics
Its receptor specificity and predictable in‑vitro behavior make Tesamorelin a valuable model compound for endocrine and metabolic research.
🧪 What Is Tesamorelin?
Tesamorelin is a synthetic GHRH analog used in laboratory research involving:
Pituitary‑axis signaling and GH‑pathway activation models
GHRH‑receptor (GHRH‑R) binding and kinetic analysis
GH/IGF‑1‑linked transcriptional signaling studies
Lipid‑metabolism and adipocyte‑signaling research
Cellular‑growth and protein‑synthesis pathway modeling
Peptide stability and degradation‑resistance profiling
Its extended stability and receptor‑specific activity support controlled, pathway‑specific experimental design.
📡 Mechanistic Research Overview (Audit‑Safe)
🧬 Endocrine Axis & GHRH‑Receptor Signaling
Referenced in studies examining GHRH‑R activation
Used in models mapping GH/IGF‑1‑associated transcriptional cascades
Supports research into pituitary‑linked cellular communication
⚖️ Metabolic Regulation & Lipid Pathway Modeling
Applied in research involving lipid‑signaling and metabolic markers
Supports investigation of adipocyte‑associated signaling pathways
Used in multi‑pathway metabolic‑regulation studies
🔋 Cellular Growth & Protein Synthesis Dynamics
Examined in GH‑linked growth‑pathway models
Supports peptide‑mediated transcriptional activation research
Used in comparative studies versus other GHRH analogs
🧱 Molecular & Chemical Characteristics
Type: Synthetic 44‑amino‑acid GHRH analog
Form: Lyophilized powder
Fill Size: 10 mg
Origin: Modified GHRH sequence for enhanced stability
Identity Verification: Mass Spectrometry (MS)
Purity Analysis: HPLC / UPLC
Structural & Biochemical Notes
Designed for predictable receptor‑binding behavior in vitro
Demonstrates strong stability in lyophilized form
Sensitive to hydrolysis and degradation following reconstitution if improperly handled
🔬 Research Focus Areas
Tesamorelin is commonly referenced in laboratory research involving:
Endocrine‑axis and pituitary‑signaling modeling
GH/IGF‑1‑linked transcriptional pathway studies
Metabolic‑regulation and lipid‑signaling assays
Peptide–receptor binding and activation analysis
Cellular‑growth and protein‑synthesis research
Multi‑pathway endocrine and metabolic investigations
Its clean mechanistic profile supports controlled, reproducible research workflows in regulated laboratory environments.
❄️ Storage & Handling Guidelines
Store lyophilized peptide at –20 °C, protected from light and moisture
Reconstituted solutions: 2–8 °C, short‑term research use only
Avoid repeated freeze–thaw cycles; aliquot where necessary
Avoid prolonged exposure to room temperature after reconstitution
Use sterile preparation techniques and low‑binding labware
📄 Certificate of Analysis & Documentation
Each batch of Tesamorelin supplied by BlueNexLabs includes audit‑ready documentation, ensuring traceability and reproducibility:
Mass Spectrometry identity confirmation
HPLC / UPLC purity profile
Solvent system disclosure
Lot and batch traceability
Research‑Use‑Only (RUO) designation
🔗 View Certificate of Analysis (COA)
🔗 Learn About Our Testing Standards
🔗 Explore the BlueNexLabs Research Peptide Catalog
🇨🇦 Supplied for Canadian Research Laboratories
BlueNexLabs supplies Tesamorelin research peptide to laboratories across Vancouver, Toronto, Montreal, Calgary, Edmonton, Ottawa, and throughout Canada.
Why Researchers Choose BlueNexLabs
🇨🇦 Canada‑wide domestic shipping
📄 COA‑verified, traceable batches
🧪 Audit‑safe RUO labeling
⚡ Fast fulfillment & responsive support
🔬 Research‑focused endocrine & metabolic peptide catalog
⚠️ Compliance Notice
This product is supplied strictly for laboratory research use only (RUO).
Not for human or veterinary use.
No medical, therapeutic, metabolic, diagnostic, or performance‑related claims are made or implied.
🧬 Tesamorelin Peptide — 10 mg
High‑Purity GHRH Analog for Endocrine Signaling, Metabolic Pathway & Cellular Regulation Research (Canada)
Tesamorelin is a high‑purity, research‑grade synthetic Growth Hormone–Releasing Hormone (GHRH) analog widely referenced in laboratory research involving pituitary‑axis signaling, GH/IGF‑1‑linked transcriptional pathways, metabolic‑regulation models, and peptide–receptor interaction dynamics.
Supplied by BlueNexLabs, Tesamorelin is provided as a lyophilized peptide (10 mg) with COA‑verified purity, analytical consistency, and audit‑safe Research‑Use‑Only (RUO) labeling, supporting reproducible experimental workflows in Canadian research environments.
🔬 Overview of Tesamorelin in Research Settings
Tesamorelin is a stabilized 44‑amino‑acid GHRH analog designed to support controlled investigation of endocrine‑axis communication and downstream metabolic signaling. In laboratory settings, it is frequently referenced in studies examining:
Pituitary‑axis and GHRH receptor (GHRH‑R) signaling
GH/IGF‑1‑associated transcriptional cascades
Metabolic‑regulation and lipid‑signaling pathways
Cellular growth and protein‑synthesis models
Peptide stability and receptor‑binding kinetics
Its receptor specificity and predictable in‑vitro behavior make Tesamorelin a valuable model compound for endocrine and metabolic research.
🧪 What Is Tesamorelin?
Tesamorelin is a synthetic GHRH analog used in laboratory research involving:
Pituitary‑axis signaling and GH‑pathway activation models
GHRH‑receptor (GHRH‑R) binding and kinetic analysis
GH/IGF‑1‑linked transcriptional signaling studies
Lipid‑metabolism and adipocyte‑signaling research
Cellular‑growth and protein‑synthesis pathway modeling
Peptide stability and degradation‑resistance profiling
Its extended stability and receptor‑specific activity support controlled, pathway‑specific experimental design.
📡 Mechanistic Research Overview (Audit‑Safe)
🧬 Endocrine Axis & GHRH‑Receptor Signaling
Referenced in studies examining GHRH‑R activation
Used in models mapping GH/IGF‑1‑associated transcriptional cascades
Supports research into pituitary‑linked cellular communication
⚖️ Metabolic Regulation & Lipid Pathway Modeling
Applied in research involving lipid‑signaling and metabolic markers
Supports investigation of adipocyte‑associated signaling pathways
Used in multi‑pathway metabolic‑regulation studies
🔋 Cellular Growth & Protein Synthesis Dynamics
Examined in GH‑linked growth‑pathway models
Supports peptide‑mediated transcriptional activation research
Used in comparative studies versus other GHRH analogs
🧱 Molecular & Chemical Characteristics
Type: Synthetic 44‑amino‑acid GHRH analog
Form: Lyophilized powder
Fill Size: 10 mg
Origin: Modified GHRH sequence for enhanced stability
Identity Verification: Mass Spectrometry (MS)
Purity Analysis: HPLC / UPLC
Structural & Biochemical Notes
Designed for predictable receptor‑binding behavior in vitro
Demonstrates strong stability in lyophilized form
Sensitive to hydrolysis and degradation following reconstitution if improperly handled
🔬 Research Focus Areas
Tesamorelin is commonly referenced in laboratory research involving:
Endocrine‑axis and pituitary‑signaling modeling
GH/IGF‑1‑linked transcriptional pathway studies
Metabolic‑regulation and lipid‑signaling assays
Peptide–receptor binding and activation analysis
Cellular‑growth and protein‑synthesis research
Multi‑pathway endocrine and metabolic investigations
Its clean mechanistic profile supports controlled, reproducible research workflows in regulated laboratory environments.
❄️ Storage & Handling Guidelines
Store lyophilized peptide at –20 °C, protected from light and moisture
Reconstituted solutions: 2–8 °C, short‑term research use only
Avoid repeated freeze–thaw cycles; aliquot where necessary
Avoid prolonged exposure to room temperature after reconstitution
Use sterile preparation techniques and low‑binding labware
📄 Certificate of Analysis & Documentation
Each batch of Tesamorelin supplied by BlueNexLabs includes audit‑ready documentation, ensuring traceability and reproducibility:
Mass Spectrometry identity confirmation
HPLC / UPLC purity profile
Solvent system disclosure
Lot and batch traceability
Research‑Use‑Only (RUO) designation
🔗 View Certificate of Analysis (COA)
🔗 Learn About Our Testing Standards
🔗 Explore the BlueNexLabs Research Peptide Catalog
🇨🇦 Supplied for Canadian Research Laboratories
BlueNexLabs supplies Tesamorelin research peptide to laboratories across Vancouver, Toronto, Montreal, Calgary, Edmonton, Ottawa, and throughout Canada.
Why Researchers Choose BlueNexLabs
🇨🇦 Canada‑wide domestic shipping
📄 COA‑verified, traceable batches
🧪 Audit‑safe RUO labeling
⚡ Fast fulfillment & responsive support
🔬 Research‑focused endocrine & metabolic peptide catalog
⚠️ Compliance Notice
This product is supplied strictly for laboratory research use only (RUO).
Not for human or veterinary use.
No medical, therapeutic, metabolic, diagnostic, or performance‑related claims are made or implied.